We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Morphic Holding Inc | NASDAQ:MORF | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.45 | -1.46% | 30.37 | 12.18 | 48.70 | 31.42 | 30.275 | 31.11 | 337,782 | 23:00:00 |
From Jun 2023 to Jun 2024
Fireside Chat InformationDate: Wednesday June 7, 2023Time: 1:00 PM ETA live webcast of the presentation will be available on the Investor section of the Morphic website, or at the link here. An archived replay will be available on the company’s website following the conference.
About Morphic TherapeuticMorphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Morphic is also advancing its pipeline and discovery activities in collaboration with Schrödinger using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.
ContactsMorphic TherapeuticChris Erdmanchris.erdman@morphictx.com617.686.1718
1 Year Morphic Chart |
1 Month Morphic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
